MBX Biosciences clinical trials we track

Check company identity source

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 10 participants (planned). After: 20 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 22 Dec 2025. After: 18 Apr 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Changes from baseline to post-treatment in glucose nadir during a standardized MMTT following 2 different dose levels of MBX 1416.. After: Measure: Changes from baseline to post-treatment in glucose nadir during a standardized MMTT following different dose levels of MBX 1416..

Check registry source